| FTASX | RIDBX | FTASX / RIDBX | |
| Total Expense Ratio | 1.17 | 1.35 | 87% |
| Annual Report Gross Expense Ratio | 1.20 | 1.35 | 89% |
| Fund Existence | 17 years | 24 years | - |
| Gain YTD | 2.263 | 2.573 | 88% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.98B | 139B | 6% |
| Annual Yield % from dividends | 1.29 | 2.96 | 44% |
| Returns for 1 year | 14.81 | 12.94 | 114% |
| Returns for 3 years | 35.23 | 25.74 | 137% |
| Returns for 5 years | 24.13 | 25.16 | 96% |
| Returns for 10 years | 88.54 | 61.22 | 145% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NWQFX | 37.43 | 0.38 | +1.03% |
| Nuveen Small/Mid Cap Value R6 | |||
| CNWIX | 24.61 | 0.05 | +0.20% |
| Calamos Evolving World Growth I | |||
| VWNFX | 48.18 | 0.05 | +0.10% |
| Vanguard Windsor II Inv | |||
| LYRBX | 29.18 | -0.05 | -0.17% |
| Lyrical US Value Equity Investor | |||
| GVIRX | 18.32 | -0.06 | -0.33% |
| Goldman Sachs US Eq Div and Premium Inv | |||